Benefits and Risks of PGD/PGS
- Helps detect known genetic diseases or chromosomal abnormalities.
- Identifies abnormal embryos, preventing unhealthy embryos from being transferred to uterus.
- Reduces multiple pregnancy risk by identifying healthy embryos for implantation.
- Decreases risk to couples or individuals with serious inherited disorders of having children affected with same problem.
Risks of preimplantation genetic testing (PGD/PGS)
- PGD and PGS require in vitro fertilization (IVF), which involves risks of ovarian hyperstimulation syndrome, multiple pregnancy, and increased risk of birth defects not related to the genetic test.
- Risk of biopsy or freezing harming the embryo(s).
- False negative results could mean an abnormal embryo is transferred to the uterus, resulting in a possible miscarriage, and healthy embryos are discarded, limiting chances of a healthy pregnancy.
- Test could reveal there are no normal embryos to transfer.
- Tests do not screen for all possible genetic diseases or disorders, so a healthy baby is not guaranteed from a tested embryo.
- Chorionic villus sampling (CVS) is a biopsy of the placenta 10-12 weeks into the pregnancy that can diagnose fetal genetic abnormalities. If an abnormality is detected, abortion may be considered.
- Amniocentesis is a procedure performed 16 to 18 weeks into pregnancy that analyzes the amniotic fluid to check for fetal genetic abnormality. If one is detected, terminating the pregnancy may be considered.
- Ultrasound, accompanied by blood tests, during pregnancy may also be able to detect abnormalities. However,,CVS or amniocentesis may be recommended to confirm a suspected diagnosis.
- If the risk of inherited disease is very high, donor eggs or donor sperm can also be used.